The Board of Control for Cricket in India (BCCI) heightened their battle with the Indian anti-doping agency over who has the right to test players for banned drugs.
Although two Indian players have reportedly failed tests carried out by the World Anti-Doping Agency (WADA) in the last three years, the BCCI have refused to allow tests on their registered by the National Anti-Doping Agency (NADA).
Rahul Johri, the BCCI chief executive, wrote to NADA and the Indian sports ministry on Friday (November 10) reaffirming the refusal to cooperate.
“It is relevant to mention here that BCCI is not a national sports federation. Accordingly, NADA does not have jurisdiction to conduct dope testing of Indian cricketers in any domestic or international event organised or under the aegis of BCCI,” wrote Johri to Navin Agarwal, the NADA chief.
Johri added that “there is no requirement for any BCCI official to coordinate with NADA for dope testing of Indian cricketers” in or out of competition. “The BCCI already has a robust dope testing mechanism which is employed for both during competitions and out-of-competitions,” he wrote.
The International Cricket Council are a signatory to the WADA code and Johri said that as an ICC member, the BCCI had implemented the ICC anti-doping rules since 2011.
The doping debate in Indian cricket escalated when WADA announced this year that a domestic player – who was not named – had tested positive for a banned drug. Pradeep Sangwan, the Delhi pace bowler, failed a drug test in 2013 too, and was banned from taking part in any BCCI-run event for 18 months as a result.
NADA on Thursday appointed Virender Sehwag and Vinay Lamba, the former Delhi batsman, to its appeals panel.